specialty medicine targeted therapy tyrosine kinase inhibitor

💊 Cyendiv 100 mg Capsule | Nintedanib | Lung Disease & Cancer Treatment | Export Supplier Cyendiv 100 mg Capsule contains Nintedanib, a targeted therapy used in the treatment of idiopathic pulmonary fibrosis (IPF) and non-small cell lung cancer (NSCLC). It works by inhibiting multiple tyrosine kinases, helping to slow disease progression and abnormal cell growth. 🔹 Product Category Specialty Medicine (Targeted Therapy / Tyrosine Kinase Inhibitor) 🔹 Composition Nintedanib 100 mg 🔹 Indications ✔ Idiopathic Pulmonary Fibrosis (IPF) ✔ Non-Small Cell Lung Cancer (NSCLC) 🔹 Key Benefits ✔ Slows progression of lung fibrosis ✔ Targeted therapy (multi-kinase inhibitor) ✔ Oral capsule (patient-friendly) ✔ Used in advanced treatment protocols 🔹 Dosage & Administration ✔ Oral capsule as prescribed ✔ Usually taken twice daily ✔ Dosage based on patient condition ✔ Under strict medical supervision 🔹 Packaging ✔ Blister / Bottle Packaging ✔ Bulk Export Available ✔ Private Labeling Supported 🔹 Certifications ✔ WHO-GMP Certified ✔ COA & COPP Available 🌍 Target Export Markets & Cities 🇺🇸 USA: New York, Los Angeles, Houston 🇬🇧 UK: London, Manchester 🇦🇪 UAE: Dubai, Abu Dhabi 🇸🇬 Singapore: Singapore 🇮🇳 India: Mumbai, Delhi, Bangalore 🇵🇭 Philippines: Manila 🇻🇳 Vietnam: Ho Chi Minh City, Hanoi 🇿🇦 South Africa: Johannesburg, Cape Town 🇳🇬 Nigeria: Lagos, Abuja 🇰🇪 Kenya: Nairobi 🇧🇷 Brazil: São Paulo 🇲🇽 Mexico: Mexico City 🇵🇪 Peru: Lima 📍 Location: Nagpur, Maharashtra, India 📦 Product Catalogue Available ✔ Oncology Medicines ✔ HIV & Antiviral Medicines ✔ Specialty Pharmaceutical Products 📞 Instant Support – Call / WhatsApp Now 📲 +91 8007161282 📲 +91 9970011496 💬 Quick replies for urgent orders & inquiries! 🌐 Visit Our Official Websites 🔹 www.pacificmedicines.com 🔹 www.indocares.com 🔹 www.indiamedexport.com 📧 Business Enquiries & Bulk Orders ✉️ sales@pacificmedicines.com 🔖 Top 10 Trending Hashtags #Nintedanib #LungDisease #PulmonaryFibrosis #NSCLC #TargetedTherapy #OncologyMedicines #PharmaExport #GlobalPharma #B2BHealthcare #IndiaPharma